MedPath

ACTEMRA

ACTEMRA

Approved
DIN Number

02350114

Drug Class

Human

Market Date

May 26, 2010

Company
HC

Hoffmann-La Roche Limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02350114
AIG Number0152713001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
L04AC07 TOCILIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification90:24.20.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

TOCILIZUMABActive
Strength: 400 MG / 20 ML
Monograph: TOCILIZUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.